In the period between May 1999 and October 2004, 48 patients with stage IIIA (N2-bulky) and stage IIIB (T4 N1-2 M0) were enrolled in this phase II trial. Patient characteristics are listed in Table 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback